Stride raises £4.6M in Seed funding to expand its health product tracking range and accelerate the launch of its StrideOne membership program in the US.
Innovate UKMorgan Stanley Inclusive & Sustainable VenturesBetter VenturesArāya Ventures
Description
Stride, a London-based developer of a preventative health and biological testing platform, raised £4.6m in Seed funding. Backers included Arāya Ventures, Better Ventures, Morgan Stanley Inclusive & Sustainable Ventures, and Innovate UK. The funds will be used to enhance their product offerings and support ongoing development. Stride aims to accelerate its commercial launch in the United States with the new capital.
Who to call at Stride, and when
A new round usually means Stride is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Stride raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Stride, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Stride. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Stride
Location
Greater London, England, United Kingdom
About
Stride is a London-based developer of a preventative health and biological testing platform. The company offers an integrated health optimization ecosystem that combines DNA, blood biomarker, and gut microbiome testing with expert dietitian consultations and proprietary high-absorption liposomal supplements. Stride aims to expand its preventative health product tracking range and accelerate the commercial launch of its StrideOne membership program. It has served over 16,000 customers globally with a high member retention rate.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Stride raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.